Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down's syndrome

Br J Obstet Gynaecol. 1989 Jun;96(6):739-41. doi: 10.1111/j.1471-0528.1989.tb03295.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniocentesis / psychology*
  • Down Syndrome / prevention & control*
  • Female
  • Humans
  • Mass Screening
  • Neural Tube Defects / prevention & control*
  • Patient Acceptance of Health Care*
  • Pregnancy
  • alpha-Fetoproteins / analysis*

Substances

  • alpha-Fetoproteins